{
    "2020-12-04": [
        [
            {
                "time": "",
                "original_text": "【招银研究|行业跟踪】生物医药行业之医药零售篇——天时回暖酿春光，药店渠道有望率先复苏",
                "features": {
                    "keywords": [
                        "生物医药",
                        "医药零售",
                        "药店渠道",
                        "复苏"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药2021年度投资策略：医保全面控费背景下，医药“四化建设”是未来投资方向【安信医药马帅团队】",
                "features": {
                    "keywords": [
                        "医药",
                        "医保控费",
                        "四化建设",
                        "投资方向"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝壳投研：5000家药店，500亿市值，大参林核心优势在哪？",
                "features": {
                    "keywords": [
                        "药店",
                        "大参林",
                        "核心优势",
                        "市值"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "杠杆资金的双刃剑！12月3日融资余额环比增长及减少最多的个股一览",
                "features": {
                    "keywords": [
                        "杠杆资金",
                        "融资余额",
                        "双刃剑"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}